Table 1

Differentiation of myeloid cells in vivo

CellsCD45.2 cells, × 106, by time after cell transfer
2 h
24 h
72 h
120 h
Bone marrowSpleenBone marrowSpleenBone marrowSpleenBone marrowSpleen
All cells 1.27 ± 0.13 0.97 ± 0.10 2.5 ± 0.29 1.82 ± 0.18 1.53 ± 0.16 0.85 ± 0.09* 3.12 ± 0.32 1.06 ± 0.11* 
Gr-1+CD11b+ 0.55 ± 0.04 0.43 ± 0.04 0.93 ± 0.09 0.14 ± 0.04* 0.77 ± 0.06 0.02 ± 0.01* 2.52 ± 0.26 0.3 ± 0.31* 
CD11c+1Ab+ 0.10 ± 0.01 0.16 ± 0.01 0.18 ± 0.02 0.37 ± 0.03 0.28 ± 0.02 0.35 ± 0.04 0.37 ± 0.04 0.67 ± 0.06* 
F4/80+Gr-1 0.32 ± 0.03 0.36 ± 0.03 0.75 ± 0.08 1.15 ± 0.12 0.42 ± 0.04 0.48 ± 0.05 0.43 ± 0.04 0.54 ± 0.06 
CellsCD45.2 cells, × 106, by time after cell transfer
2 h
24 h
72 h
120 h
Bone marrowSpleenBone marrowSpleenBone marrowSpleenBone marrowSpleen
All cells 1.27 ± 0.13 0.97 ± 0.10 2.5 ± 0.29 1.82 ± 0.18 1.53 ± 0.16 0.85 ± 0.09* 3.12 ± 0.32 1.06 ± 0.11* 
Gr-1+CD11b+ 0.55 ± 0.04 0.43 ± 0.04 0.93 ± 0.09 0.14 ± 0.04* 0.77 ± 0.06 0.02 ± 0.01* 2.52 ± 0.26 0.3 ± 0.31* 
CD11c+1Ab+ 0.10 ± 0.01 0.16 ± 0.01 0.18 ± 0.02 0.37 ± 0.03 0.28 ± 0.02 0.35 ± 0.04 0.37 ± 0.04 0.67 ± 0.06* 
F4/80+Gr-1 0.32 ± 0.03 0.36 ± 0.03 0.75 ± 0.08 1.15 ± 0.12 0.42 ± 0.04 0.48 ± 0.05 0.43 ± 0.04 0.54 ± 0.06 

Gr-1+ cells were isolated from bone marrow of control C57BL/6 mice using magnetic beads. More than 92% of these cells were Gr-1+CD11b+. Fifteen million of the cells were injected intravenously into congenic CD45.1+ mice. Spleen and bone marrow were collected 2, 24, 48, and 72 hours after the injection. Each time point included 3 mice. Cells were labeled with antibodies against different surface markers and the total number of CD45+ donors' cells as well as CD45+CD11c+1Ab+ DCs, CD45+F4/80+Gr-1 macrophages, and CD45+Gr-1+CD11b+ immature myeloid cells were calculated. Mean ± SE of 3 performed experiments is shown.

*

Statistically significant differences between bone marrow and spleen (P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal